CLINICAL TRIALS PROFILE FOR CIMZIA
✉ Email this page to a colleague
All Clinical Trials for CIMZIA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00245765 ↗ | Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy | Completed | UCB Pharma | Phase 2 | 2005-10-01 | A study to assess the safety and efficacy of 2 different doses of CDP870 versus placebo, administered during 12 weeks, to patients suffering from moderate to severe chronic plaque psoriasis, extended by a 12 to 24 week follow-up. |
NCT00329303 ↗ | Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis | Completed | UCB Pharma | Phase 2 | 2006-04-01 | The primary objective is to assess differences in PASI scores between Week 12 of Study C87040 [NCT00245765] and Week 12 of re-treatment in this study. |
NCT00580840 ↗ | Dosing Flexibility Study in Patients With Rheumatoid Arthritis | Completed | UCB Pharma | Phase 4 | 2007-12-01 | During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and 4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and 16. At Wk 18 patients will be grouped as responders or non-responders based on results of the ACR20 at Week 16. |
NCT00717236 ↗ | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | Completed | UCB Pharma | Phase 3 | 2008-07-01 | This is a Phase IIIb multicenter study to evaluate the safety and efficacy of certolizumab pegol (CZP) administered to patients with moderate-to-severe rheumatoid arthritis. |
NCT00753454 ↗ | Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) | Completed | UCB Pharma | Phase 3 | 2008-09-01 | The purpose of this study is to continue to assess the safety of certolizumab pegol in combination with methotrexate (MTX). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CIMZIA
Condition Name
Clinical Trial Locations for CIMZIA
Trials by Country
Clinical Trial Progress for CIMZIA
Clinical Trial Phase
Clinical Trial Sponsors for CIMZIA
Sponsor Name